aTYR PHARMA Inc (ATYR) insider trading
Every open-market stock purchase and sale by aTYR PHARMA Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $6.3K over the last 12 months (3 sales).
- Last insider buy: Paul Schimmel (Insider), $49.6K, 5 months ago.
Last 12 months: insiders bought $49.6K (1 buy) and sold $6.3K (3 sales). Last close $0.17 on Oct 22, 2026.
Recent ATYR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Brandon Yaras (CFO) | Bought (not open market) | — |
| May 27, 2026 | Paul Schimmel (Insider) | Bought | $49.6K |
| May 11, 2026 | Timothy Coughlin (Insider) | Bought (not open market) | — |
| May 11, 2026 | Svetlana Lucas (Insider) | Bought (not open market) | — |
| May 11, 2026 | Sara Zaknoen (Insider) | Bought (not open market) | — |
| May 11, 2026 | Paul Schimmel (Insider) | Bought (not open market) | — |
| May 11, 2026 | Jane A Gross (Insider) | Bought (not open market) | — |
| May 11, 2026 | Eric Benevich (Insider) | Bought (not open market) | — |
| Feb 4, 2026 | Sanjay Shukla (CEO) | Sold | $3.7K |
| Feb 4, 2026 | Jill Marie Broadfoot (CFO) | Sold | $1.5K |
| Feb 4, 2026 | Nancy Denyes (General Counsel) | Sold | $1.1K |
| Feb 3, 2026 | Jill Marie Broadfoot (CFO) | Bought (not open market) | — |
| Feb 3, 2026 | Nancy Denyes (General Counsel) | Bought (not open market) | — |
| Feb 3, 2026 | Sanjay Shukla (CEO) | Bought (not open market) | — |
| Jan 9, 2026 | Nancy Denyes (General Counsel) | Bought (not open market) | — |
| Jan 9, 2026 | Jill Marie Broadfoot (CFO) | Bought (not open market) | — |
| Jan 9, 2026 | Sanjay Shukla (CEO) | Bought (not open market) | — |
Who's trading ATYR
- Brandon Yaras, CFO: other filings, last Oct 1, 2026
- Paul Schimmel, Insider: bought $49.6K (1 buy), last May 27, 2026
- Sara Zaknoen, Insider: other filings, last May 11, 2026
- Timothy Coughlin, Insider: other filings, last May 11, 2026
- Jane A Gross, Insider: other filings, last May 11, 2026
- Svetlana Lucas, Insider: other filings, last May 11, 2026
- Eric Benevich, Insider: other filings, last May 11, 2026
- Nancy Denyes, General Counsel: sold $1.1K (1 sale), last Feb 4, 2026
- Sanjay Shukla, CEO: sold $3.7K (1 sale), last Feb 4, 2026
- Jill Marie Broadfoot, CFO: sold $1.5K (1 sale), last Feb 4, 2026
Get free alerts when an insider at aTYR PHARMA Inc files a new trade →